Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics
Fierce Pharma
FEBRUARY 7, 2023
Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics fkansteiner Tue, 02/07/2023 - 10:08
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Fierce Pharma
FEBRUARY 7, 2023
Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics fkansteiner Tue, 02/07/2023 - 10:08
Copyright Clearance Center
APRIL 16, 2024
In a publishing environment buffeted by digital disruption and calls for open access, university presses in 2024 must manage to remain relevant and sustainable even as their audiences grow.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
DECEMBER 9, 2022
Senator presses Amgen with 'final request' for information in tax probe. Fri, 12/09/2022 - 09:50.
Fierce Pharma
APRIL 5, 2024
Amid ongoing drug shortages and other headline-grabbing issues that fall under the FDA’s purview, the House Committee on Oversight and Accountability is putting the agency’s commissioner Robert Cal | The April 11 hearing could be contentious, as the committee wants to “hold the commissioner accountable" for the FDA's action on drug shortages, (..)
Copyright Clearance Center
FEBRUARY 26, 2024
SPD takes risks on books by new or marginalized writers, enabling their works to develop an audience and to gain recognition, says Kent Watson.
Copyright Clearance Center
SEPTEMBER 10, 2023
The post Arcadia Endowment Supports MIT Press Open Access “Experiments” appeared first on Copyright Clearance Center.
Referral MD
JULY 26, 2022
Since 2019, Press Ganey has gathered patient surveys to produce an annual report of what is driving them to pick one provider over another. The methodology of the Press Ganey survey and its key findings. What percentage of patients refuse to see a provider with lower than a 4-star review average.
Fierce Pharma
MAY 13, 2024
While much of the fanfare around COVID-19 treatments has dissipated, Shionogi has continued to press on in hopes that its Japan-approved protease inhibitor ensitrelvir could compete on a global sta | While much of the fanfare around COVID-19 treatments has dissipated, Shionogi has continued to press on in hopes that its Japan-approved protease inhibitor (..)
Healthcare Success
MAY 2, 2022
As more businesses favor social media channels for timely business communications, you may think press releases have become outdated or old-fashioned. You might even ask yourself, “Do we even need press releases anymore?” Why You Need a Press Release. There are many benefits of publishing press releases.
Copyright Clearance Center
JANUARY 30, 2023
The post What’s New at Oxford University Press Is Everything appeared first on Copyright Clearance Center.
pharmaphorum
APRIL 9, 2024
Bayer enlists the aid of Google Cloud to develop its AI platform for radiologists, adding genAI capabilities
Healthcare Success
MAY 2, 2022
As more businesses favor social media channels for timely business communications, you may think press releases have become outdated or old-fashioned. You might even ask yourself, "Do we even need press releases anymore?" . Why You Need a Press Release. There are many benefits of publishing press releases.
Fierce Pharma
MARCH 25, 2024
officials are pressing the company to pay royalties linked to the commercialization of its lucrative Pfizer-partnered COVID-19 vaccine. Even as Germany's BioNTech deals with ongoing declines of its revenue and share price, it's facing another serious concern: U.S.
Fierce Pharma
JANUARY 16, 2024
As Bayer’s new CEO Bill Anderson kicks off his first full year at the helm with an objective to revamp the company, a prominent German trade union is pressing to keep the large conglomerate togethe | As new CEO Bill Anderson presses on with his strategic review, Germany's IG BCE is taking issue with potential German job losses that could stem (..)
Fierce Pharma
MARCH 19, 2024
In moments of great uncertainty, sometimes the best approach is to just press on. CDMO WuXi AppTec reported solid performance in 2023 and expects good things for the coming year, too. Still, the Chinese contract manufacturer finds itself embroiled in a national security crackdown in the U.S.,
Fierce Pharma
JANUARY 19, 2024
The lawsuit marks the latest move in Pfizer’s campaign to press countries to honor COVID-19 vaccine contracts inked by the European Commission in May 2021. . | Following public spats with Hungary and Poland, Pfizer and its German mRNA partner BioNTech have kicked off legal proceedings against Romania.
Fierce Pharma
FEBRUARY 13, 2024
After proposing a bill to revoke funding from certain Chinese biopharmas, a group of bipartisan legislators penned a letter to certain White House officials pressing for sanctions on the two companies based on alleged links to China's Communist Party and its military.
MedCity News
JANUARY 24, 2023
Solving the labor shortage in healthcare requires that organizations come together and try new strategies leveraging their own data to better understand what their teams need.
Fierce Pharma
OCTOBER 2, 2023
The deal will see the asset manager furnish Amicus with a $400 million loan that will be used for the refinancing of existing debt, Amicus said in a press release. . | Amicus unveiled a $430 million financing pact with Blackstone Life Sciences and Blackstone Credit.
Dominic Tyer
APRIL 11, 2024
Online changes pose some pressing questions for the industry and demand a new approach to websites and data
Pharmaceutical Technology
OCTOBER 31, 2023
Sellas will be meeting with the FDA in Q4 2023 to discuss Breakthrough Therapy Designation for SLS009 as a treatment for r/r PTCL.
PharmaVoice
MARCH 1, 2024
Impatience to fix long-held challenges to overseas drug facility inspections is growing on Capitol Hill.
Fierce Pharma
AUGUST 15, 2023
Responding to recent acquisition rumors, Stada Arzneimittel's CEO Peter Goldschmidt told the German Press Agency, “Whether and when STADA might be sold is solely the decision of our owners; Bain Capital and Cinven.”
PharmaVoice
JUNE 20, 2023
It’s exciting to be part of today’s gene therapy development community; however, three issues are at the top of the industry’s mind—the regulatory landscape, critical molecular bioanalysis considerations: biodistribution, transgene expression, vector shedding and assay-related challenges.
Fierce Pharma
NOVEMBER 7, 2023
Now, though, an investigation in France calls into question some of the c | France's Parquet National Financier opened a preliminary investigation into Sanofi's financial communications during Dupixent's 2017 launch, according to press reports.
Pharmacy Times
APRIL 23, 2024
On April 17 and 18, hundreds of independent community pharmacists came to Capitol Hill in Washington, D.C., to participate in the National Community Pharmacists Association’s Congressional Pharmacy Fly-In.
World of DTC Marketing
NOVEMBER 27, 2020
SUMMARY: Business by press release has made pharma executives a lot of money but we still haven’t seen any over reviewed data on COVID 19 vaccines. The results of trials were announced in press releases rather than peer-reviewed papers. Science by press release.
pharmaphorum
MAY 6, 2024
The Novo Nordisk Foundation, the Bill & Melinda Gates Foundation, and Wellcome have joined forces to tackle some of the most pressing threats to human health and wellbeing.
MedCity News
NOVEMBER 22, 2022
A new venture capital firm named HC9 Ventures recently launched and announced the close of a $83 million fund. It is led by three healthcare industry veterans, and its more than 125 investors are “intentionally and only healthcare executives,” according to HC9 Co-Founder Richard Lungen.
Fierce Pharma
JUNE 5, 2023
Victoria Summers, principal at ZS Associates, discusses one of the most pressing challenges facing the pharma industry today: patient centricity. One of the hottest topics shaping the world of pharmaceuticals and medicine is patient centricity. How can the industry better engage with the people who rely on its products and services?
Pharmaceutical Technology
DECEMBER 1, 2023
Hot on the heels of the designation, Orchard Therapeutics is pressing ahead with a multi-centre trial for the candidate with a start date in December.
MedCity News
DECEMBER 6, 2023
The company’s product, called Canopy Protect, involves wearable monitors that healthcare staff can press when they feel threatened, as well as a system that allows a hospital to monitor all physical areas of the organization.
PharmaVoice
JUNE 5, 2023
Now, after steadying the ship, she’s brought the trade association’s focus back to the industry’s most pressing priorities. Rachel King took the reins at BIO during a rocky time.
Contrarian Sales Techniques
DECEMBER 17, 2023
A message touting a "Done-For-You AI Press Release Writer" promised page 1 rankings faster than ever before, without the usual "complicated process, expensive fees, and tons of work." Here's the magic: No expensive PR writer fees : This AI whiz wrote my press releases, saving me hundreds of bucks and countless hours of writer wrangling.
MedCity News
AUGUST 31, 2023
With nursing faculty also in short supply and a wave rapidly approaching retirement age, virtual reality simulations can help bridge the gap between learners needing supervised clinical experiences, and time-pressed preceptors, who have their own patients to care for in addition to guiding novices in clinical settings.
Pharmaceutical Technology
JANUARY 8, 2024
The layoffs and scaling back of R&D activities will extend Senti Biosciences' cash runway into Q1 2025, according to a press release.
MedCity News
MARCH 6, 2024
At the ViVE event in Los Angeles last month, health tech executives shared how their companies are putting innovative ideas into action to address the most pressing needs in healthcare, as part of the Vibe at ViVE by MedCity News.
MedCity News
FEBRUARY 1, 2023
Here are three ways to solve the most pressing problems. Security threats are not going away any time soon. In fact, they are on the rise and likely will be for years to come.
MedCity News
JUNE 7, 2023
On any given day there may be more pressing issues to handle, and many companies believe “it won’t happen to us” – that is, until it does happen to you, and then it’s more important than ever to be prepared and confident with your crisis communications plan.
MedCity News
FEBRUARY 28, 2023
Maintaining patient safety and ensuring HIPAA-compliance are also pressing factors. Within the healthcare sector, the migration of CRMs faces even bigger challenges due to the sheer amount and dispersion of data. Nonetheless, the results of a CRM migration are definitely worth it.
MedCity News
JULY 26, 2022
The goal is to extend its available cash as the company presses on with commercialization efforts for its digital therapeutics. Pear Therapeutics is implementing a corporate restructuring projected to save about $28 million.
PharmaTech
OCTOBER 3, 2023
The new customized system is designed for fully automated and integrated labeling, orientation, and palletization, and it is expected to streamline the current manual processes, according to the press release.
PharmaTech
OCTOBER 18, 2023
These results will provide insights from more than 250 global pharma executives, including discoveries such as pharma confidence dipping below the record scores of 2022, although it has remained extremely resilient despite wider macro uncertainly, according to the press release.
PharmaTech
SEPTEMBER 26, 2023
BenevolentAI will leverage its suite of AI chemistry design tools in combination with its fully equipped wet lab facility in Cambridge, UK, to deliver small molecule drug development candidates into the Merck pipeline, according to the press release.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content